Pricing

Log inSign up

Cour Pharmaceuticals Development

0 followers

‌

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Industries

Biotechnology, Pharmaceutical

Headquarters

Elmhurst, United States

Employees

11-50

Links

Org chart

John J. Puisis
Co-Founder & President & CEO

John J. Puisis

Collapse
Brian C. Bock
CFO
Dannielle Appelhans
President And Chief Executive Officer
Adam Elhofy
VP, Immunology & Innovation
Robert Hodge
VP of Technical Development
PA
Pooja Agashe
Intellectual Property and Business Analyst
Sandeep Kakade
Senior Formulations & Product Development Scientist
Lori Jester
Vice President Of Manufacturing And Supply Chain
Ashorena Michael
Accountant

Teams

+9

Advisory and Executive Roles

12 members

IK
+7

Research and Development

10 members

+5

Leadership Team

8 members

+1

Finance and Accounting

4 members

BL
PA

Regulatory Affairs and Compliance

3 members

Similar companies

Immunome

2 followers

Vial

5 followers

Abbott

277 followers

Thermo Fisher Scientific

155 followers

BeiGene

19 followers

Catalent

17 followers

Cytiva

10 followers

Apellis Pharmaceuticals

7 followers

Amgen

200 followers

Merck

211 followers

Curia Global

4 followers

Explore companies